Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Neoplasms, Second Primary
×
Temozolomide
×
Clear all
Filters
3
NCT00638963
2017-06-14
STOP
Merck Sharp & Dohme LLC
Phase 2
Terminated
6 enrolled
9 charts
NCT00629187
2012-04-27
CN-306
Tufts Medical Center
Phase 1
Terminated
2 enrolled